NCT05536934View on ClinicalTrials.gov

Arginase Inhibition in Humans With Obesity

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

September 30, 2021

Study Completion Date

March 31, 2022

Conditions
ObeseEndothelial Function
Interventions
DRUG

Nω-hydroxy-nor-arginine

Trial Locations (1)

17176

Karolinska Institutet, Karolinska University Hospital, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT05536934 - Arginase Inhibition in Humans With Obesity | Biotech Hunter | Biotech Hunter